TABLE 1.
Target Cells | HLA-DR Expression | Preloaded Protein† | Introduced Gene‡ | BR-B8§ | B104|| |
---|---|---|---|---|---|
Media | None | — | None | 0 | 0 |
293-DR4 | DR4+ | — | MART-1 | 52 | nt |
293-DR4 | DR4+ | — | gp100 | 1,908 | nt |
293-DR7 | DR7+ | — | MART-1 | 0 | 1 |
293-DR7 | DR7+ | — | gp100 | 20 | 4,349 |
F002Rmel CIITA | DR7+ | — | GFP | 16 | 12 |
F002Rmel CIITA | DR7+ | — | gp100 | 11 | 13,686 |
624mel CIITA | DR4+ DR7+ | — | — | 2,278 | 354 |
1861mel CIITA | DR4+ | — | — | 5,746 | 5 |
Donor 1 PBMC | DR4+ DR7+ | — | — | 16 | 0 |
Donor 1 PBMC | DR4+ DR7+ | NY-ESO-1 | — | 25 | 1,107 |
Donor 1 PBMC | DR4+ DR7+ | gp100 | — | 6,151 | 15,123 |
Donor 2 PBMC | DR4+ DR7+ | — | — | 27 | 12 |
Donor 2 PBMC | DR4+ DR7+ | NY-ESO-1 | — | 37 | 428 |
Donor 2 PBMC | DR4+ DR7+ | gp100 | — | 5,956 | 12,500 |
Donor 3 PBMC | DR4+ DR7+ | — | — | 37 | 23 |
Donor 3 PBMC | DR4+ DR7+ | NY-ESO-1 | — | 13 | 225 |
Donor 3 PBMC | DR4+ DR7+ | gp100 | — | 2,818 | 6,850 |
INF-γ secretion (pg/mL) in 20-hour coculture supernatants of target cells with T lymphocytes.
Recombinant proteins were preloaded onto PBMC at 10 νg/mL overnight at 37°C.
The indicated genes were transfected into 293 cells or retrovirally transduced into F002mel CIITA cells.
BR-B8 is a CD4+ T cell line that specifically recognizes gp100:44–59 in the context of HLA-DRβ1*0401.
B104 is a CD4+ T cell clone that specifically recognizes gp100:170–190 in the context of HLA-DRβ1*0701.
Note. Underlined values indicate that INF-γ secretion in response to target cells expressing gp100 and either HLA-DRβ1*0701 or HLA-DRβ1*0401 was ≥ 100 pg/mL and at least twice background with relevant control target cells.